E-LIB Suche - Ergebnisse für: Mokhtarani, M.

1

Overt hepatic encephalopathy: development of a novel clinic..:

Bajaj, J. S. ; Frederick, R. T. ; Bass, N. M....
Metabolic Brain Disease. 31 (2016) 5 - p. 1081-1093 , 2016

Link: https://doi.org/10.1007/..

2

Glutamine and hyperammonemic crises in patients with urea c..:

Lee, B. ; Diaz, G.A. ; Rhead, W....
Molecular Genetics and Metabolism. 117 (2016) 1 - p. 27-32 , 2016

Link: https://doi.org/10.1016/..

3

Prospective Multicenter Observational Study of Overt Hepati..:

Landis, C. S. ; Ghabril, M. ; Rustgi, V....
Digestive Diseases and Sciences. 61 (2016) 6 - p. 1728-1734 , 2016

Link: https://doi.org/10.1007/..

4

Urinary phenylacetylglutamine (U-PAGN) concentration as bio..:

Mokhtarani, M. ; Diaz, G.A. ; Lichter-Konecki, U....
Molecular Genetics and Metabolism Reports. 5 (2015) - p. 12-14 , 2015

Link: https://doi.org/10.1016/..

5

Population Pharmacokinetic Modeling and Dosing Simulations ..:

Monteleone, Jon P. R. ; Mokhtarani, M. ; Diaz, G. A....
The Journal of Clinical Pharmacology. 53 (2013) 7 - p. 699-710 , 2013

Link: https://doi.org/10.1002/..

6

Elevated phenylacetic acid levels do not correlate with adv..:

Mokhtarani, M. ; Diaz, G.A. ; Rhead, W....
Molecular Genetics and Metabolism. 110 (2013) 4 - p. 446-453 , 2013

Link: https://doi.org/10.1016/..

7

248 FASTING AMMONIA (NH3) AS A PREDICTOR OF HEPATIC ENCEPHA..:

Vierling, J.M. ; Mokhtarani, M. ; Brown Jr., R.S....
Journal of Hepatology. 58 (2013) - p. S106 , 2013

Link: https://doi.org/10.1016/..

8

Randomized controlled trial of atorvastatin in clinically i..:

Waubant, E. ; Pelletier, D. ; Mass, M....
Neurology. 78 (2012) 15 - p. 1171-1178 , 2012

Link: https://doi.org/10.1212/..

9

Urinary phenylacetylglutamine as dosing biomarker for patie..:

Mokhtarani, M. ; Diaz, G.A. ; Rhead, W....
Molecular Genetics and Metabolism. 107 (2012) 3 - p. 308-314 , 2012

Link: https://doi.org/10.1016/..

10

Ammonia control in children with urea cycle disorders (UCDs..:

Lichter-Konecki, Uta ; Diaz, G.A. ; Merritt II, J.L....
Molecular Genetics and Metabolism. 103 (2011) 4 - p. 323-329 , 2011

Link: https://doi.org/10.1016/..

11

Omalizumab pretreatment decreases acute reactions after rus..:

CASALE, T ; BUSSE, W ; KLINE, J...
Journal of Allergy and Clinical Immunology. 117 (2006) 1 - p. 134-140 , 2006

Link: https://doi.org/10.1016/..

12

(778):

Hefti, F. ; Mokhtarani, M. ; Gray, M...
The Journal of Pain. 7 (2006) 4 - p. S45 , 2006

Link: https://doi.org/10.1016/..

13

A50 RN624 (ANTI-NERVE GROWTH FACTOR ANTIBODY) EFFECTIVELY R..:

Mokhtarani, M. ; Zhao, C. ; Gray, M...
Osteoarthritis and Cartilage. 14 (2006) - p. S41-S42 , 2006

Link: https://doi.org/10.1016/..

14

Omalizumab pretreatment prevents allergic reactions due to ..:

Casale, T.B. ; Kline, J.N. ; Busse, W.W....
Journal of Allergy and Clinical Immunology. 115 (2005) 2 - p. S65 , 2005

Link: https://doi.org/10.1016/..

15

Omalizumab plus rush immunotherapy (RIT) is more effective ..:

Kline, J.N. ; Casale, T.B. ; Busse, W.W....
Journal of Allergy and Clinical Immunology. 115 (2005) 2 - p. S207 , 2005

Link: https://doi.org/10.1016/..